This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is It Worth Investing in Spotify (SPOT) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Spotify (SPOT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SPOTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About New Gold (NGD): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), New Gold (NGD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NGDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Roblox (RBLX): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Roblox (RBLX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
RBLXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Sunoco LP (SUN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Sunoco LP (SUN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SUNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Camtek (CAMT) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Camtek (CAMT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CAMTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Lam Research (LRCX) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Lam Research (LRCX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LRCXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in ARKO (ARKO) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for ARKO (ARKO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ARKONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Skechers (SKX) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Skechers (SKX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
broker-rating earnings-estimates-revisions earnings-growth
Is Blue Bird (BLBD) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Blue Bird (BLBD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BLBDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is CrowdStrike (CRWD) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CrowdStrike (CRWD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRWDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Bit Digital (BTBT) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Bit Digital (BTBT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BTBTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Energy Fuels (UUUU) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Energy Fuels (UUUU). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
UUUUNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Modine (MOD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Modine (MOD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MODPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Synchronoss (SNCR) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Synchronoss (SNCR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SNCRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Applied Materials (AMAT) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Applied Materials (AMAT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AMATNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in PulteGroup (PHM): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), PulteGroup (PHM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PHMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Gladstone Commercial (GOOD) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Gladstone Commercial (GOOD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
GOODNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Arch Capital (ACGL): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Arch Capital (ACGL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ACGLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Palo Alto (PANW): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Palo Alto (PANW) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PANWNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Seanergy Maritime Holdings (SHIP) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Seanergy Maritime Holdings (SHIP) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SHIPPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
ACM Research (ACMR) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), ACM Research (ACMR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ACMRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Booking Holdings (BKNG) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Booking Holdings (BKNG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BKNGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BSXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is HCI Group (HCI) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in HCI Group (HCI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HCINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is AZZ (AZZ) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AZZ (AZZ). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AZZNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth